Aims The relevance of lipoprotein (a)[Lp (a)] concentrations and low-molecular-weight
(LMW) apo (a) phenotypes in peripheral arterial disease (PAD) has only been investigated …

Abstract Lipoprotein (a)[Lp (a)] represents an LDL-like particle to which the Lp (a)-specific
apolipoprotein (a) is linked via a disulfide bridge. It has gained considerable interest as a …

Background Cardiovascular disease (CVD) is a major cause of mortality and morbidity.
Increased low-density lipoprotein cholesterol (LDL-C) level is its major risk factor. Familial …

Røsby O, Berg K (University of Oslo and Ullevål University Hospital, Oslo, Norway). LPA
gene: interaction between the apolipoprotein (a) size ('kringle IV'repeat) polymorphism and …

Background The concentrations of the highly atherogenic lipoprotein (a)[Lp (a)] are mainly
genetically determined by the LPA gene locus. However, up to 70% of the coding sequence …

Most of the Interindividual variations in plasma levels of lipoprotein (a)[Lp (a)] can be
attributed to sequence differences linked to the apolipoprotein (a)[apo (a)] locus. Plasma …

Elevated levels of lipoprotein (a) are associated with an increased risk of myocardial
infarction. Our study aimed to test whether genetic data are consistent with this association …

Genetic variation in several genes involved in lipid metabolism is known to affect population
variation in quantitative lipid risk factor profiles for coronary heart disease (CHD). The …

Objective—Lp (a)(lipoprotein (a)) concentrations are widely genetically determined by the
LPA isoforms and show 5-fold interpopulation differences. Two-to 3-fold differences have …

Background Lipoprotein (a) is an atherogenic low-density lipoprotein–like particle and
circulating levels are largely determined by genetics. Patients with familial …